Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q00266
UPID:
METK1_HUMAN
Alternative names:
Methionine adenosyltransferase 1; Methionine adenosyltransferase I/III
Alternative UPACC:
Q00266; D3DWD5; Q5QP09
Background:
S-adenosylmethionine synthase isoform type-1, also known as Methionine adenosyltransferase 1, plays a pivotal role in methionine metabolism. It catalyzes the formation of S-adenosylmethionine (AdoMet), a critical methyl donor involved in numerous metabolic processes.
Therapeutic significance:
Methionine adenosyltransferase deficiency, linked to this protein, highlights its importance in metabolic pathways. Understanding the role of S-adenosylmethionine synthase isoform type-1 could open doors to potential therapeutic strategies for treating metabolic disorders.